Halfords eyes garage growth after wheels fall off cycling boom June 18, 2026 Retail and autocentre giant Halfords will deliver its full-year results next week, hoping to deliver sustained growth after a Covid-era bike boom. Felix Armstrong profiles the FTSE stalwart Head to the very back of a Halfords store, snaking your way round the air fresheners, tents, brake fluid and torches, and you will find the bike [...]
D-Wave Announces World’s First Gate-Model Quantum Computing Simulator for Error-Aware Programming June 18, 2026 New offering to help developers prototype applications, model quantum processor behavior and explore advanced workflows as they prepare for access to forthcoming D-Wave™ gate-model systems
bet365 WC26 Tournament Challenge Review 2026: Win Up to £250,000 June 18, 2026 With the 2026 World Cup now underway, bet365 has launched the WC26 Tournament Challenge, a free prediction game that gives eligible customers a shot at winning real cash prizes and Bet Credits without placing a single bet. In this review, we take a close look at how the game works, what the prize structure looks [...]
Tesco fuel sales drag up slowing growth June 18, 2026 Tesco has revealed a nearly 20 per cent boost in fuel sales as the Iran war sends petrol prices soaring, dragging up otherwise slowing revenue. The FTSE 100 supermarket saw fuel sales jump by 19.5 per cent to £1.7bn in the three months to May, while total sales growth slowed to one per cent to [...]
Finimize data: Fees alone won’t win UK retail investors June 18, 2026 Finimize reveals the best platforms and products as voted for by UK retail investors Fragmentation: Platform rankings vary significantly by wealth and investing experience, challenging the idea of an “average” retail investor The £50k divide: Higher-value investors prioritise trust, service and investment range, with different platforms leading in this segment Fees are table stakes: Low costs remain important, but investors are weighing up trust, usability and product quality alongside price
Andy Haldane: Britain after Brexit June 18, 2026 The UK economy is suffering from deep-seated psychological scarring caused by a sequence of crises, which necessitates a strategic re-imagining of the state’s role in generating growth, says Andy Haldane We are fast approaching the ten-year anniversary of Brexit – an event that is sure to leave a large and lasting scar on our economy, [...]
Politics and football have more in common than you think June 18, 2026 If politics is showbiz for ugly people, it might also be seen as sport for the unathletic. It often carries the same partisanship, the obsession with obscure statistics, and the familiar pattern of renewed hope, only to be dampened by reality, says John Oxley By the time you read things, two things will have happened [...]
Exclusive: O2 Arena bosses open to hosting another Formula 1 launch event June 18, 2026 O2 Arena bosses are open to hosting another Formula 1 launch event if the motor racing series decides to repeat its popular pre-season showpiece. To celebrate its 75th season, Formula 1 staged a sell-out event at the 20,000-capacity O2 in Greenwich, with all teams showing off their cars alongside music from the likes of Machine Gun [...]
Kemi Badenoch pledges to wield the axe on post-financial crisis banking regulation June 18, 2026 Kemi Badenoch will today step up her efforts to woo the City as she promises to wield the axe on post-financial crisis banking regulation if she manages to clinch the keys to Number 10. “London is having its lunch eaten” by overregulation, the Tory leader will proclaim as she proposes a shakeup of the financial regime that she hopes [...]
Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 2 at SLEEP 2026 June 17, 2026 — First Large Phase 2 Study of an Orexin 2 Receptor Agonist to Demonstrate Clinically Meaningful and Statistically Significant Improvements in Wakefulness and Excessive Daytime Sleepiness Compared to Placebo in Narcolepsy Type 2 — — Improvements in Wakefulness and Patient-Reported Cognition and Fatigue Were Sustained Through 13 Weeks — — Alixorexton Was Generally Well Tolerated at All Doses Tested —